MedTrace Logo

Analgesic Strategies in Newborns Receiving Prostaglandin Therapy

NCT00200590 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2008-04-21

No results posted yet for this study

Summary

This is a randomised trial comparing the efficacy of 3 different analgesic strategies in newborns on prostaglandin for ductus dependent congenital heart disease.

Conditions

Interventions

DRUG

acetaminophen and nalbuphine

DRUG

acetaminophen and morphine

DRUG

acetaminophen and reduced dosage of prostaglandin

Sponsors & Collaborators

  • Nantes University Hospital

    lead OTHER

Principal Investigators

  • Véronique Gournay, MD · Nantes UH

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
28 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-12-31
Primary Completion
2006-07-31
Completion
2006-07-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00200590 on ClinicalTrials.gov